These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 6444529

  • 1. The inhibition of high and low molecular weight urokinase in plasma.
    Murano G, Aronson D, Williams L, Brown L.
    Blood; 1980 Mar; 55(3):430-6. PubMed ID: 6444529
    [Abstract] [Full Text] [Related]

  • 2. Comparative study of the activity of high and low molecular weight urokinase in the presence of fibrin.
    Samama M, Castel M, Matsuo O, Hoylaerts M, Lijnen HR.
    Thromb Haemost; 1982 Feb 26; 47(1):36-40. PubMed ID: 7041325
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Different molecular forms of plasminogen and plasmin produced by urokinase in human plasma and their relation to protease inhibitors and lysis of fibrinogen and fibrin.
    Müllertz S.
    Biochem J; 1974 Nov 26; 143(2):273-83. PubMed ID: 4282470
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Complex-formation and inhibition of urokinase by blood plasma proteins.
    Waller EK, Schleuning WD, Reich E.
    Biochem J; 1983 Oct 01; 215(1):123-31. PubMed ID: 6194790
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Measurement of human urokinase activity in plasma by using mono-specific antibody-conjugated paper disk.
    Ogiso T, Ito Y, Iwaki M, Atago H.
    J Biochem; 1987 Mar 01; 101(3):671-7. PubMed ID: 2439494
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [The changes of alpha 2-plasmin inhibitor, and notably urokinase activities in blood measured by synthetic chromogenic substrates S-2444 after urokinase administration].
    Itoh Y, Tsuji K, Tanaka N, Yamada M, Nakanishi M, Ishihara M, Kobayashi M.
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Jan 01; 35(1):68-76. PubMed ID: 6338134
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of the in vitro fibrinolytic activities of low and high molecular weight single-chain urokinase-type plasminogen activator.
    de Munk GA, Groeneveld E, Rijken DC.
    Thromb Haemost; 1993 Sep 01; 70(3):481-5. PubMed ID: 8259553
    [Abstract] [Full Text] [Related]

  • 16. Identification and some properties of a new fast-reacting plasmin inhibitor in human plasma.
    Collen D.
    Eur J Biochem; 1976 Oct 01; 69(1):209-16. PubMed ID: 136345
    [Abstract] [Full Text] [Related]

  • 17. Demonstration of urokinase-related fibrinolytic activity in human plasma.
    Wijngaards G, Kluft C, Groeneveld E.
    Br J Haematol; 1982 May 01; 51(1):165-9. PubMed ID: 7041952
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Immunochemical studies of high and low molecular forms of urokinase.
    Sumi H, Toki N, Maehara S, Kosugi T, Akazawa K, Matsuo O, Mihara H.
    Acta Haematol; 1982 May 01; 67(4):263-7. PubMed ID: 6810625
    [Abstract] [Full Text] [Related]

  • 20. Inhibitor of plasminogen activator in human arterial wall. II. Biochemical characterization.
    Okamura T, Nanno S, Sueishi K, Tanaka K.
    Acta Pathol Jpn; 1984 Jul 01; 34(4):749-57. PubMed ID: 6237547
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.